Guoqiang Dong - Concepedia

Author

Guoqiang Dong

Second Military Medical University ORCID

Also Known As

Dong G, Dong, Guoqiang, Guixia Dong, Guo-Qiang Dong, GuoQiang Dong, Guoqiang Dong, Xunkui Yin

174

Publications

6.3K

Citations

H-Index

Concepts

All Affiliations

Second Military Medical University East China University of Science and Technology Shanghai University University of New Mexico Northwestern University

About

Guoqiang Dong is an author at Second Military Medical University specializing in drug discovery, medicine, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	28	52	2.5K
2	Natural Sciences	24	36	1.8K
3	Biochemistry	19	26	1.2K
4	Engineering	4	4	175
5	Health Sciences	4	4	392

Guoqiang Dong

107

Publications

4.8K

Citations

H-Index

Page 1

	Year	Citations
Aptamer‐PROTAC Conjugates (APCs) for Tumor‐Specific Targeting in Breast Cancer Shipeng He, Fei Gao, Junhui Ma, Angewandte Chemie International Edition Breast OncologyBet-targeting ProtacTumor BiologyMedicinal ChemistryVivo Bet Degradation	2021	259
Scaffold Diversity Inspired by the Natural Product Evodiamine: Discovery of Highly Potent and Multitargeting Antitumor Agents Shengzheng Wang, Kun Fang, Guoqiang Dong, Journal of Medicinal Chemistry Medicinal ChemistryNatural Product SynthesisDiversity Oriented SynthesisBiochemistryMedicine	2015	189
New Tricks for an Old Natural Product: Discovery of Highly Potent Evodiamine Derivatives as Novel Antitumor Agents by Systemic Structure–Activity Relationship Analysis and Biological Evaluations Guoqiang Dong, Shengzheng Wang, Zhenyuan Miao, Journal of Medicinal Chemistry Pharmaceutical ScienceOld Natural ProductNovel Antitumor AgentsPharmacotherapyPharmaceutical Chemistry	2012	179
Selection of Evodiamine as a Novel Topoisomerase I Inhibitor by Structure-Based Virtual Screening and Hit Optimization of Evodiamine Derivatives as Antitumor Agents Guoqiang Dong, Chunquan Sheng, Shengzheng Wang, Journal of Medicinal Chemistry Pharmaceutical ScienceBioorganic ChemistryChemoprevention StrategyPharmacotherapyPharmaceutical Chemistry	2010	145
Potent Dual BET/HDAC Inhibitors for Efficient Treatment of Pancreatic Cancer Shipeng He, Guoqiang Dong, Yu Li, Angewandte Chemie International Edition	2020	140
Discovery, Synthesis, and Biological Evaluation of Orally Active Pyrrolidone Derivatives as Novel Inhibitors of p53–MDM2 Protein–Protein Interaction Chunlin Zhuang, Zhenyuan Miao, Lingjian Zhu, Journal of Medicinal Chemistry PharmacotherapyChemistryChemical BiologyPharmaceutical ChemistryMedicinal Chemistry	2012	128
Fulvic acid ameliorates drought stress-induced damage in tea plants by regulating the ascorbate metabolism and flavonoids biosynthesis Jianhao Sun, Chen Qiu, Yiqian Ding, BMC Genomics	2020	126
Three-Dimensional Model of Lanosterol 14α-Demethylase from <i>Cryptococcus neoformans</i> : Active-Site Characterization and Insights into Azole Binding Chunquan Sheng, Zhenyuan Miao, Haitao Ji, Antimicrobial Agents and Chemotherapy Molecular BiologyChemical BiologyDrug ResistanceThree-dimensional ModelAzole Binding	2009	114
Small Molecule Inhibitors Simultaneously Targeting Cancer Metabolism and Epigenetics: Discovery of Novel Nicotinamide Phosphoribosyltransferase (NAMPT) and Histone Deacetylase (HDAC) Dual Inhibitors Guoqiang Dong, Wei Chen, Xia Wang, Journal of Medicinal Chemistry	2017	103
Discovery of Janus Kinase 2 (JAK2) and Histone Deacetylase (HDAC) Dual Inhibitors as a Novel Strategy for the Combinational Treatment of Leukemia and Invasive Fungal Infections Yahui Huang, Guoqiang Dong, Huanqiu Li, Journal of Medicinal Chemistry Novel JanusImmunologyJanus Kinase 2PathologyDrug Resistance	2018	96

Page 1